Federal Independent Agencies
Here's a look at documents from federal independent agencies
Federal Independent Agencies
Featured Stories
U.S. Helsinki Commission: Briefing--Generation Victory - How Ukraine is Educating Students in Wartime
WASHINGTON, Nov. 17 -- The Commission on Security and Cooperation in Europe, also known as the U.S. Helsinki Commission, issued the following news release:
* * *
BRIEFING--Generation Victory: How Ukraine is Educating Students in Wartime
November 16, 2026
Russia is attempting to demoralize and destroy Ukrainian culture and society, including by deliberately attacking civilian institutions such as schools and universities. Ukraine's human rights commissioner reports that nearly five thousand educational institutions have been damaged and nearly five hundred destroyed since the beginning of Russia's ... Show Full Article WASHINGTON, Nov. 17 -- The Commission on Security and Cooperation in Europe, also known as the U.S. Helsinki Commission, issued the following news release: * * * BRIEFING--Generation Victory: How Ukraine is Educating Students in Wartime November 16, 2026 Russia is attempting to demoralize and destroy Ukrainian culture and society, including by deliberately attacking civilian institutions such as schools and universities. Ukraine's human rights commissioner reports that nearly five thousand educational institutions have been damaged and nearly five hundred destroyed since the beginning of Russia'sfull-scale invasion. Bombing attacks on printing and logistics sites this summer destroyed nearly 1.2 million textbooks. UNICEF reports that 4.6 million children are facing barriers to education including air-raid alerts and strikes that keep students in shelters or at home, close schools, and halt in-person and online learning.
At the same time, from the Covid pandemic through Russia's full-scale invasion, Ukrainian universities, schools, and students are adapting and evolving to meet the challenge. Displaced universities have moved to Kyiv and created communities to serve academics and students living in exile. Volunteers and students are addressing gaps in education and preparing Ukraine's young people for success in the work force. Technical and vocational schools are anticipating supporting the reintegration of Ukrainian military veterans. Ukraine's education of its young people is central to its resistance to Russia's genocidal pressure, and Ukraine's hard-won experience provides lessons in the role of education as the foundation of freedom.
Panelists:
Natalia Etten, advisory board member and former CEO, Teach for Ukraine
Archbishop-Metropolitan Borys Gudziak, president of the Ukrainian Catholic University
Oksana Nechyporenko, co-founder, Go Global and non-resident senior fellow, Atlantic Council
* * *
Original text here: https://www.csce.gov/press-releases/briefing-generation-victory-how-ukraine-is-educating-students-in-wartime
* * *
BRIEFING--Generation Victory: How Ukraine is Educating Students in Wartime
November 16, 2026
Russia is attempting to demoralize and destroy Ukrainian culture and society, including by deliberately attacking civilian institutions such as schools and universities. Ukraine's human rights commissioner reports that nearly five thousand educational institutions have been damaged and nearly five hundred destroyed since the beginning of Russia's ... Show Full Article WASHINGTON, Nov. 17 -- The Commission on Security and Cooperation in Europe, also known as the U.S. Helsinki Commission, issued the following news release: * * * BRIEFING--Generation Victory: How Ukraine is Educating Students in Wartime November 16, 2026 Russia is attempting to demoralize and destroy Ukrainian culture and society, including by deliberately attacking civilian institutions such as schools and universities. Ukraine's human rights commissioner reports that nearly five thousand educational institutions have been damaged and nearly five hundred destroyed since the beginning of Russia'sfull-scale invasion. Bombing attacks on printing and logistics sites this summer destroyed nearly 1.2 million textbooks. UNICEF reports that 4.6 million children are facing barriers to education including air-raid alerts and strikes that keep students in shelters or at home, close schools, and halt in-person and online learning.
At the same time, from the Covid pandemic through Russia's full-scale invasion, Ukrainian universities, schools, and students are adapting and evolving to meet the challenge. Displaced universities have moved to Kyiv and created communities to serve academics and students living in exile. Volunteers and students are addressing gaps in education and preparing Ukraine's young people for success in the work force. Technical and vocational schools are anticipating supporting the reintegration of Ukrainian military veterans. Ukraine's education of its young people is central to its resistance to Russia's genocidal pressure, and Ukraine's hard-won experience provides lessons in the role of education as the foundation of freedom.
Panelists:
Natalia Etten, advisory board member and former CEO, Teach for Ukraine
Archbishop-Metropolitan Borys Gudziak, president of the Ukrainian Catholic University
Oksana Nechyporenko, co-founder, Go Global and non-resident senior fellow, Atlantic Council
* * *
Original text here: https://www.csce.gov/press-releases/briefing-generation-victory-how-ukraine-is-educating-students-in-wartime
NASA Receives 16th Consecutive 'Clean' Financial Audit Opinion
WASHINGTON, Nov. 17 -- NASA issued the following news release:
* * *
NASA Receives 16th Consecutive 'Clean' Financial Audit Opinion
Nov 16, 2026
For the 16th consecutive year, NASA has received an unmodified, or "clean," opinion from an external auditor on its fiscal year 2026 financial statements.
The rating is the best possible audit opinion, certifying that NASA's financial statements conform with Generally Accepted Accounting Principles for federal agencies and accurately present the agency's financial position.
"Our responsibility at NASA is to be disciplined stewards of the resources ... Show Full Article WASHINGTON, Nov. 17 -- NASA issued the following news release: * * * NASA Receives 16th Consecutive 'Clean' Financial Audit Opinion Nov 16, 2026 For the 16th consecutive year, NASA has received an unmodified, or "clean," opinion from an external auditor on its fiscal year 2026 financial statements. The rating is the best possible audit opinion, certifying that NASA's financial statements conform with Generally Accepted Accounting Principles for federal agencies and accurately present the agency's financial position. "Our responsibility at NASA is to be disciplined stewards of the resourcesentrusted to us by the American people while delivering on the missions they expect from this agency," said NASA Administrator Jared Isaacman. "Our 16th consecutive clean audit reflects a long record of financial accountability, and we intend to pair that discipline with the urgency and execution required to take on the near-impossible missions ahead."
The 2026 Agency Financial Report provides key financial and performance information and demonstrates the agency's commitment to transparency in the use of American taxpayers' dollars. In addition, the 2026 report presents progress during the past year, and spotlights advancements in NASA missions, objectives, and workforce development with these financial resources.
In fiscal year 2026 (FY 2026), NASA's 10-day Artemis II mission successfully accomplished a test flight around the Moon with four crew members, delivering major human spaceflight milestones, such as the record breaking distance astronauts have traveled from Earth and global public engagement. NASA also announced a series of transformative agencywide initiatives designed to advance American leadership in space, including plans to build a Moon Base, which will be humanity's first lunar outpost, and a place where astronauts will live, work, and explore near the Moon's South Pole.
NASA's science advancements in FY 2026 included launching the agency's Nancy Grace Roman Space Telescope, ahead of schedule, to study dark matter, dark energy, planets outside our solar system, as well as exploration of everything from nearby stars to distant galaxies. NASA's experimental X-59 quiet supersonic aircraft achieved a major milestone when it flew faster than the speed of sound for the first time.
The agency also: launched NASA Force with the U.S. Office of Personnel Management, a talent track designed to recruit and deploy the nation's top engineers and technologists to support America's space program; announced an agencywide realignment to increase mission focus; and welcomed additional Artemis Accords signatories committing to the safe, transparent, and responsible exploration of the Moon, Mars, and beyond.
For more information on NASA's budget, visit:
https://www.nasa.gov/budget
* * *
Original text here: https://www.nasa.gov/news-release/nasa-receives-16th-consecutive-clean-financial-audit-opinion/
* * *
NASA Receives 16th Consecutive 'Clean' Financial Audit Opinion
Nov 16, 2026
For the 16th consecutive year, NASA has received an unmodified, or "clean," opinion from an external auditor on its fiscal year 2026 financial statements.
The rating is the best possible audit opinion, certifying that NASA's financial statements conform with Generally Accepted Accounting Principles for federal agencies and accurately present the agency's financial position.
"Our responsibility at NASA is to be disciplined stewards of the resources ... Show Full Article WASHINGTON, Nov. 17 -- NASA issued the following news release: * * * NASA Receives 16th Consecutive 'Clean' Financial Audit Opinion Nov 16, 2026 For the 16th consecutive year, NASA has received an unmodified, or "clean," opinion from an external auditor on its fiscal year 2026 financial statements. The rating is the best possible audit opinion, certifying that NASA's financial statements conform with Generally Accepted Accounting Principles for federal agencies and accurately present the agency's financial position. "Our responsibility at NASA is to be disciplined stewards of the resourcesentrusted to us by the American people while delivering on the missions they expect from this agency," said NASA Administrator Jared Isaacman. "Our 16th consecutive clean audit reflects a long record of financial accountability, and we intend to pair that discipline with the urgency and execution required to take on the near-impossible missions ahead."
The 2026 Agency Financial Report provides key financial and performance information and demonstrates the agency's commitment to transparency in the use of American taxpayers' dollars. In addition, the 2026 report presents progress during the past year, and spotlights advancements in NASA missions, objectives, and workforce development with these financial resources.
In fiscal year 2026 (FY 2026), NASA's 10-day Artemis II mission successfully accomplished a test flight around the Moon with four crew members, delivering major human spaceflight milestones, such as the record breaking distance astronauts have traveled from Earth and global public engagement. NASA also announced a series of transformative agencywide initiatives designed to advance American leadership in space, including plans to build a Moon Base, which will be humanity's first lunar outpost, and a place where astronauts will live, work, and explore near the Moon's South Pole.
NASA's science advancements in FY 2026 included launching the agency's Nancy Grace Roman Space Telescope, ahead of schedule, to study dark matter, dark energy, planets outside our solar system, as well as exploration of everything from nearby stars to distant galaxies. NASA's experimental X-59 quiet supersonic aircraft achieved a major milestone when it flew faster than the speed of sound for the first time.
The agency also: launched NASA Force with the U.S. Office of Personnel Management, a talent track designed to recruit and deploy the nation's top engineers and technologists to support America's space program; announced an agencywide realignment to increase mission focus; and welcomed additional Artemis Accords signatories committing to the safe, transparent, and responsible exploration of the Moon, Mars, and beyond.
For more information on NASA's budget, visit:
https://www.nasa.gov/budget
* * *
Original text here: https://www.nasa.gov/news-release/nasa-receives-16th-consecutive-clean-financial-audit-opinion/
Reaching the Right Cell: The Future of Targeted Treatment Delivery
WASHINGTON, Nov. 16 -- The National Academy of Medicine issued the following news:
* * *
Reaching the Right Cell: The Future of Targeted Treatment Delivery
*
NAM Emerging Leader in Health and Medicine Raman Bahal is exploring new frontiers in precision medicine at UConn, where his laboratory is developing ways to deliver treatments to specific cells while limiting damage to healthy tissue.
Among the various instruments that line the workstations in Raman Bahal's laboratory sits an unassuming box of cards, each carrying a message from family and friends of children impacted by cancer. The cards ... Show Full Article WASHINGTON, Nov. 16 -- The National Academy of Medicine issued the following news: * * * Reaching the Right Cell: The Future of Targeted Treatment Delivery * NAM Emerging Leader in Health and Medicine Raman Bahal is exploring new frontiers in precision medicine at UConn, where his laboratory is developing ways to deliver treatments to specific cells while limiting damage to healthy tissue. Among the various instruments that line the workstations in Raman Bahal's laboratory sits an unassuming box of cards, each carrying a message from family and friends of children impacted by cancer. The cardscame from families connected to the foundation that helped fund Bahal's research when he established his lab at the University of Connecticut in 2017. When I visited in September, he opened the box to share some of these messages. He keeps them in the lab, he explained, as a reminder to his students of the people their work could someday help.
Much of that work aims to fundamental challenge in drug development: knowing how to design a treatment that acts on a disease does not mean knowing how to get it to the cells that need it.
Bahal, a professor of pharmaceutics at the University of Connecticut School of Pharmacy and Pharmaceutical Sciences, was selected for the Victor J. Dzau Emerging Leaders in Health and Medicine program at the National Academy of Medicine (NAM) in 2025.
Researchers in Bahal's laboratory design synthetic molecules that bind to specific DNA or RNA sequences and examine how they can disrupt or regulate these genetic instructions. The goal is to develop treatments that modify key processes involved the development of genetic diseases and cancer. Some of their work targets messenger RNA (mRNA), a single-stranded genetic molecule that carries a gene's instructions for making a protein, and microRNAs (miRNA), which help regulate the process of protein production. Other projects focus on DNA itself, primarily investigating ways to prevent select genetic instructions from being read.
Alongside these efforts, the lab develops novel therapeutic delivery systems, including tiny carriers and chemical guides. Reaching an organ is not enough; a given drug must be able to enter the appropriate cells and get to the place inside them where it can act. According to Bahal, that kind of precision can limit harm to healthy tissue in addition to being more efficient overall.
"You don't want to fix one process and mess up with the other," he emphasized.
Learning to look beyond the experiment
Although a career in research and drug development wasn't originally on his radar, Bahal had been drawn to science since childhood. Growing up in a small town in Punjab, India, he knew that students interested in science typically followed 1 of 2 paths: medicine or engineering. Still, his curiosity had a way of reaching beyond those familiar options. By ninth grade, he was reading his older sister's chemistry textbooks, seeking out scientific material well beyond what he was learning in school. His interest eventually led him to a scholarship-supported master's program at the National Institute of Pharmaceutical Education and Research (NIPER) in Mohali. With his father as the family's sole earner, the scholarship helped ease the financial burden of his education. It was there that Bahal began to see research as a possible career. Encouraged by his sister, who also became a chemist, he considered doctoral programs abroad and ultimately joined chemist Danith Ly's laboratory at Carnegie Mellon University.
When Bahal brought Ly a research proposal, his adviser pressed him on what he would do if an experiment failed. What would he try next? Where did he ultimately want the work to lead? Bahal began to appreciate the thinking that went into those decisions, and by the third year of his doctorate, he had decided to pursue an academic career.
Learning molecular biology alongside chemistry also made him curious about what happens to a molecule once it leaves the chemist's bench and enters a living organism. During his postdoctoral training in Peter Glazer's laboratory at Yale, he began attending lab meetings with Glazer's collaborator, biomedical engineer W. Mark Saltzman., Although he formally belonged to only one laboratory, he was encouraged to learn from both. Bahal soon began presenting his work to both groups, learning about drug delivery and discussing projects with both mentors.
Given his own career path, it is fitting that a cross-disciplinary approach is central to Bahal's research philosophy. He encourages students to look beyond their own specialties and understand each stage of a project, helping them identify unanswered questions and recognize when to draw on expertise from other fields.
His role at NAM offers opportunities for further interdisciplinary exchanges, this time with professionals whose work includes clinical care, population health, and health policy. He serves a three-year term among the Victor J. Dzau Emerging Leaders in Health and Medicine (ELHM) Scholars, who participate in NAM activities and connect with its members and other scholars.
How Small Chemical Shifts Can Change a Molecule's Course
In his own laboratory, Bahal began exploring a question that required both kinds of knowledge. Scientists had found ways to guide nucleic acid medicines to liver cells using carbohydrate molecules. He wondered if other carbohydrates could be leveraged to achieve similar outcomes.
Enter lactobionic acid, a carbohydrate that Bahal's team had shown could help direct molecules to the liver. When they changed parts of its chemical structure, the modified carbohydrate molecules showed a preference for the kidneys instead.
"These results were especially compelling given the kidney's vital role: it led me to wonder what was going on here," Bahal recalled.
Small chemical changes had altered where the molecules went. Understanding why meant looking more closely at the cells they entered.
Carbohydrates can act as ligands, a molecule that binds to a receptor on a cell's surface.
Some receptors will draw the carbohydrates into the cell itself. By chemically attaching a medicine to a specific carbohydrate, which Bahal refers to as a "molecular zip code," researchers can accordingly use this mechanism to help carry the treatment into the cell. However, because the same receptor may be present on multiple cell types, identifying a molecule that binds to a receptor does not necessarily predict where the attached medicine will go. Working with Yale Stefan Somlo, Bahal's team investigated the behavior of chemically-modified lactobionic acid in mice. Their work produced a novel delivery system called RENTAC, short for renal tubule-targeting carbohydrate. In a 2024 study, published in Molecular Therapy, the researchers showed that attached molecules reached cells in kidney structures called proximal tubules and remained in the kidneys for several days.
They also used RENTAC to carry an experimental molecule designed to block a miRNA involved in kidney scarring. Treated mice developed less scar tissue after experiencing chemically-induced kidney injury. Treatment began before the injury, however, so the findings do not establish that the approach reverses existing scarring. Nor do these animal studies establish safety or effectiveness in people.
Bahal co-founded Zeal Therapeutics to further pursue development of this kidney-targeted delivery technology. That next step brings a whole new set of questions, including whether molecules made in small amounts can be manufactured at a larger scale without compromising their stability.
Back in the laboratory, those questions take shape through a series of experiments designed to reveal how the molecules behave and whether they work as intended.
During my September visit, doctoral student Sai Pallavi Pradeep, explained how comparing treated and untreated cells helps reveal whether a potential treatment changes a gene's activity. The team extracts RNA and measures how much of a particular mRNA molecule is present; this provides one measure of the treatment's effect. The researchers then must investigate what that change means for the cell.
Other tests help assess safety, including screening animal blood samples for potential signs of harm. Researchers also demonstrated how they separate newly made compounds before testing to ensure they can identify each individual molecule.
For doctoral student Mounika Pathuri, who trained in pharmaceutical science, this work represents the future of drug development.
"Individualized health care is finally starting to become a reality," she said.
Delivering on the Promise of Precision Medicine
In an accompanying NAM Perspectives discussion paper, Using AI and Machine Learning to Advance Nucleic Acid Therapeutic Delivery Beyond the Liver, Bahal and colleagues consider how researchers could make the search for new delivery routes like RENTAC more systematic. The authors include two members of his lab, assistant research professor Vikas Kumar and doctoral student Sai Pallavi Pradeep, along with Saltzman and UConn toxicologist Jose E. Manautou.
The development of RENTAC offers a case study in both the promise and complexity of this search. A chemical change can alter where a molecule goes, but researchers cannot readily predict which changes will prove useful. Artificial intelligence and machine learning could help them select more promising candidates before making and testing them.
For example, computational models could suggest which chemical structures are likely to bind to a receptor. Information about where that receptor occurs in the body could then help researchers assess whether the interaction might direct a medicine toward the intended cells or send it elsewhere.
Live experiments would still be essential to the development process, Bahal and his coauthors assured. A cell can take in a potential medicine but trap it in an internal compartment, preventing it from reaching the genetic information it is supposed to act on. Disease can also change the receptors a cell carries, making predictions based on healthy tissue unreliable. The authors propose using experimental results to improve the models, so subsequent predictions better reflect what happens in living systems.
Those delivery challenges also shape his cancer research, the work that brought those families' cards into the lab. For the DNA-targeting treatments his team is investigating, reaching the right organ would be only the beginning. The molecules must enter the intended cells, reach the nucleus, and bind to a specific part of the DNA.
His team uses peptide nucleic acids, or PNAs, synthetic molecules designed to recognize matching sequences in DNA or RNA. They bind to genetic material much as natural DNA and RNA strands pair, but their different chemical structure makes them harder for enzymes to break down.
The goal is to prevent selected genetic instructions from being carried out without affecting the DNA code. Blocking transcription, the process of copying those instructions into mRNA, could reduce the production of a protein involved in tumor growth.
In a 2026 study published in Precision Oncology, the researchers targeted the VEGFA gene, which encodes a protein involved in blood-vessel growth and tumor development. Their approach slowed tumor growth in a mouse model of triple-negative breast cancer.
Centering the People Behind the Science
For Bahal, the larger goal is to move beyond simply controlling or curing disease and reduce the physical toll of care. Chemotherapy, for example, can be used to manage or even cure cancer, but it can also harm healthy cells that divide rapidly, including those in the digestive tract and hair follicles. That damage can contribute to negative side effects like nausea, mouth sores, and hair loss. More precise drug delivery could help limit that collateral damage, allowing patients to experience fewer or less severe side effects during treatment,
Bahal envisions treatment given by injection or infusion that could travel to the affected organ, enter the cancer cells, and interfere with the processes sustaining the tumor while limiting damage to healthy tissue. Making that possible would require both the delivery system and the treatment itself to work as intended. A molecule that recognizes a genetic target cannot help a patient if it never reaches that target; one that reaches a tumor still needs to act effectively once inside its cells.
This vision remains a work in progress. Further research is needed to determine whether the approach can safely and effectively treat cancer without causing cells to become treatment resistant. Still, Bahal says that the oncologists he speaks with all ultimately agree that, even without a cure, controlling disease while helping patients feel better during treatment would be meaningful progress.
"If you can ... improve the quality of a patient's life, that's a big success," he said.
For Bahal, the complexities of research and drug development should never overshadow the reason for pursuing them in the first place: improving patients' lives. In his office, photographs of his own family sit alongside a picture of a young patient connected to the foundation that supported his early cancer research. Alongside the cards that he displays for his students, these photographs serve as tangible reminders of the people at the heart of his work.
"It truly motivates us to keep going," Bahal said. "Research is demanding work that requires substantial time and careful consideration. Nevertheless, the team's efforts are essential to developing new medications that may ultimately benefit patients and their families."
Read more about Dr. Bahal's work in the following publication: Using AI and Machine Learning to Advance Nucleic Acid Therapeutic Delivery Beyond the Liver.
***
Original text here: https://nam.edu/news-and-insights/reaching-the-right-cell-targeted-therapy/
* * *
Reaching the Right Cell: The Future of Targeted Treatment Delivery
*
NAM Emerging Leader in Health and Medicine Raman Bahal is exploring new frontiers in precision medicine at UConn, where his laboratory is developing ways to deliver treatments to specific cells while limiting damage to healthy tissue.
Among the various instruments that line the workstations in Raman Bahal's laboratory sits an unassuming box of cards, each carrying a message from family and friends of children impacted by cancer. The cards ... Show Full Article WASHINGTON, Nov. 16 -- The National Academy of Medicine issued the following news: * * * Reaching the Right Cell: The Future of Targeted Treatment Delivery * NAM Emerging Leader in Health and Medicine Raman Bahal is exploring new frontiers in precision medicine at UConn, where his laboratory is developing ways to deliver treatments to specific cells while limiting damage to healthy tissue. Among the various instruments that line the workstations in Raman Bahal's laboratory sits an unassuming box of cards, each carrying a message from family and friends of children impacted by cancer. The cardscame from families connected to the foundation that helped fund Bahal's research when he established his lab at the University of Connecticut in 2017. When I visited in September, he opened the box to share some of these messages. He keeps them in the lab, he explained, as a reminder to his students of the people their work could someday help.
Much of that work aims to fundamental challenge in drug development: knowing how to design a treatment that acts on a disease does not mean knowing how to get it to the cells that need it.
Bahal, a professor of pharmaceutics at the University of Connecticut School of Pharmacy and Pharmaceutical Sciences, was selected for the Victor J. Dzau Emerging Leaders in Health and Medicine program at the National Academy of Medicine (NAM) in 2025.
Researchers in Bahal's laboratory design synthetic molecules that bind to specific DNA or RNA sequences and examine how they can disrupt or regulate these genetic instructions. The goal is to develop treatments that modify key processes involved the development of genetic diseases and cancer. Some of their work targets messenger RNA (mRNA), a single-stranded genetic molecule that carries a gene's instructions for making a protein, and microRNAs (miRNA), which help regulate the process of protein production. Other projects focus on DNA itself, primarily investigating ways to prevent select genetic instructions from being read.
Alongside these efforts, the lab develops novel therapeutic delivery systems, including tiny carriers and chemical guides. Reaching an organ is not enough; a given drug must be able to enter the appropriate cells and get to the place inside them where it can act. According to Bahal, that kind of precision can limit harm to healthy tissue in addition to being more efficient overall.
"You don't want to fix one process and mess up with the other," he emphasized.
Learning to look beyond the experiment
Although a career in research and drug development wasn't originally on his radar, Bahal had been drawn to science since childhood. Growing up in a small town in Punjab, India, he knew that students interested in science typically followed 1 of 2 paths: medicine or engineering. Still, his curiosity had a way of reaching beyond those familiar options. By ninth grade, he was reading his older sister's chemistry textbooks, seeking out scientific material well beyond what he was learning in school. His interest eventually led him to a scholarship-supported master's program at the National Institute of Pharmaceutical Education and Research (NIPER) in Mohali. With his father as the family's sole earner, the scholarship helped ease the financial burden of his education. It was there that Bahal began to see research as a possible career. Encouraged by his sister, who also became a chemist, he considered doctoral programs abroad and ultimately joined chemist Danith Ly's laboratory at Carnegie Mellon University.
When Bahal brought Ly a research proposal, his adviser pressed him on what he would do if an experiment failed. What would he try next? Where did he ultimately want the work to lead? Bahal began to appreciate the thinking that went into those decisions, and by the third year of his doctorate, he had decided to pursue an academic career.
Learning molecular biology alongside chemistry also made him curious about what happens to a molecule once it leaves the chemist's bench and enters a living organism. During his postdoctoral training in Peter Glazer's laboratory at Yale, he began attending lab meetings with Glazer's collaborator, biomedical engineer W. Mark Saltzman., Although he formally belonged to only one laboratory, he was encouraged to learn from both. Bahal soon began presenting his work to both groups, learning about drug delivery and discussing projects with both mentors.
Given his own career path, it is fitting that a cross-disciplinary approach is central to Bahal's research philosophy. He encourages students to look beyond their own specialties and understand each stage of a project, helping them identify unanswered questions and recognize when to draw on expertise from other fields.
His role at NAM offers opportunities for further interdisciplinary exchanges, this time with professionals whose work includes clinical care, population health, and health policy. He serves a three-year term among the Victor J. Dzau Emerging Leaders in Health and Medicine (ELHM) Scholars, who participate in NAM activities and connect with its members and other scholars.
How Small Chemical Shifts Can Change a Molecule's Course
In his own laboratory, Bahal began exploring a question that required both kinds of knowledge. Scientists had found ways to guide nucleic acid medicines to liver cells using carbohydrate molecules. He wondered if other carbohydrates could be leveraged to achieve similar outcomes.
Enter lactobionic acid, a carbohydrate that Bahal's team had shown could help direct molecules to the liver. When they changed parts of its chemical structure, the modified carbohydrate molecules showed a preference for the kidneys instead.
"These results were especially compelling given the kidney's vital role: it led me to wonder what was going on here," Bahal recalled.
Small chemical changes had altered where the molecules went. Understanding why meant looking more closely at the cells they entered.
Carbohydrates can act as ligands, a molecule that binds to a receptor on a cell's surface.
Some receptors will draw the carbohydrates into the cell itself. By chemically attaching a medicine to a specific carbohydrate, which Bahal refers to as a "molecular zip code," researchers can accordingly use this mechanism to help carry the treatment into the cell. However, because the same receptor may be present on multiple cell types, identifying a molecule that binds to a receptor does not necessarily predict where the attached medicine will go. Working with Yale Stefan Somlo, Bahal's team investigated the behavior of chemically-modified lactobionic acid in mice. Their work produced a novel delivery system called RENTAC, short for renal tubule-targeting carbohydrate. In a 2024 study, published in Molecular Therapy, the researchers showed that attached molecules reached cells in kidney structures called proximal tubules and remained in the kidneys for several days.
They also used RENTAC to carry an experimental molecule designed to block a miRNA involved in kidney scarring. Treated mice developed less scar tissue after experiencing chemically-induced kidney injury. Treatment began before the injury, however, so the findings do not establish that the approach reverses existing scarring. Nor do these animal studies establish safety or effectiveness in people.
Bahal co-founded Zeal Therapeutics to further pursue development of this kidney-targeted delivery technology. That next step brings a whole new set of questions, including whether molecules made in small amounts can be manufactured at a larger scale without compromising their stability.
Back in the laboratory, those questions take shape through a series of experiments designed to reveal how the molecules behave and whether they work as intended.
During my September visit, doctoral student Sai Pallavi Pradeep, explained how comparing treated and untreated cells helps reveal whether a potential treatment changes a gene's activity. The team extracts RNA and measures how much of a particular mRNA molecule is present; this provides one measure of the treatment's effect. The researchers then must investigate what that change means for the cell.
Other tests help assess safety, including screening animal blood samples for potential signs of harm. Researchers also demonstrated how they separate newly made compounds before testing to ensure they can identify each individual molecule.
For doctoral student Mounika Pathuri, who trained in pharmaceutical science, this work represents the future of drug development.
"Individualized health care is finally starting to become a reality," she said.
Delivering on the Promise of Precision Medicine
In an accompanying NAM Perspectives discussion paper, Using AI and Machine Learning to Advance Nucleic Acid Therapeutic Delivery Beyond the Liver, Bahal and colleagues consider how researchers could make the search for new delivery routes like RENTAC more systematic. The authors include two members of his lab, assistant research professor Vikas Kumar and doctoral student Sai Pallavi Pradeep, along with Saltzman and UConn toxicologist Jose E. Manautou.
The development of RENTAC offers a case study in both the promise and complexity of this search. A chemical change can alter where a molecule goes, but researchers cannot readily predict which changes will prove useful. Artificial intelligence and machine learning could help them select more promising candidates before making and testing them.
For example, computational models could suggest which chemical structures are likely to bind to a receptor. Information about where that receptor occurs in the body could then help researchers assess whether the interaction might direct a medicine toward the intended cells or send it elsewhere.
Live experiments would still be essential to the development process, Bahal and his coauthors assured. A cell can take in a potential medicine but trap it in an internal compartment, preventing it from reaching the genetic information it is supposed to act on. Disease can also change the receptors a cell carries, making predictions based on healthy tissue unreliable. The authors propose using experimental results to improve the models, so subsequent predictions better reflect what happens in living systems.
Those delivery challenges also shape his cancer research, the work that brought those families' cards into the lab. For the DNA-targeting treatments his team is investigating, reaching the right organ would be only the beginning. The molecules must enter the intended cells, reach the nucleus, and bind to a specific part of the DNA.
His team uses peptide nucleic acids, or PNAs, synthetic molecules designed to recognize matching sequences in DNA or RNA. They bind to genetic material much as natural DNA and RNA strands pair, but their different chemical structure makes them harder for enzymes to break down.
The goal is to prevent selected genetic instructions from being carried out without affecting the DNA code. Blocking transcription, the process of copying those instructions into mRNA, could reduce the production of a protein involved in tumor growth.
In a 2026 study published in Precision Oncology, the researchers targeted the VEGFA gene, which encodes a protein involved in blood-vessel growth and tumor development. Their approach slowed tumor growth in a mouse model of triple-negative breast cancer.
Centering the People Behind the Science
For Bahal, the larger goal is to move beyond simply controlling or curing disease and reduce the physical toll of care. Chemotherapy, for example, can be used to manage or even cure cancer, but it can also harm healthy cells that divide rapidly, including those in the digestive tract and hair follicles. That damage can contribute to negative side effects like nausea, mouth sores, and hair loss. More precise drug delivery could help limit that collateral damage, allowing patients to experience fewer or less severe side effects during treatment,
Bahal envisions treatment given by injection or infusion that could travel to the affected organ, enter the cancer cells, and interfere with the processes sustaining the tumor while limiting damage to healthy tissue. Making that possible would require both the delivery system and the treatment itself to work as intended. A molecule that recognizes a genetic target cannot help a patient if it never reaches that target; one that reaches a tumor still needs to act effectively once inside its cells.
This vision remains a work in progress. Further research is needed to determine whether the approach can safely and effectively treat cancer without causing cells to become treatment resistant. Still, Bahal says that the oncologists he speaks with all ultimately agree that, even without a cure, controlling disease while helping patients feel better during treatment would be meaningful progress.
"If you can ... improve the quality of a patient's life, that's a big success," he said.
For Bahal, the complexities of research and drug development should never overshadow the reason for pursuing them in the first place: improving patients' lives. In his office, photographs of his own family sit alongside a picture of a young patient connected to the foundation that supported his early cancer research. Alongside the cards that he displays for his students, these photographs serve as tangible reminders of the people at the heart of his work.
"It truly motivates us to keep going," Bahal said. "Research is demanding work that requires substantial time and careful consideration. Nevertheless, the team's efforts are essential to developing new medications that may ultimately benefit patients and their families."
Read more about Dr. Bahal's work in the following publication: Using AI and Machine Learning to Advance Nucleic Acid Therapeutic Delivery Beyond the Liver.
***
Original text here: https://nam.edu/news-and-insights/reaching-the-right-cell-targeted-therapy/
NJ TRANSIT and Amtrak Mark Historic Milestone as Portal North Bridge Enters Full Service
WASHINGTON, Nov. 16 -- Amtrak (National Railroad Passenger Corp.) issued the following news:
* * *
NJ TRANSIT and Amtrak Mark Historic Milestone as Portal North Bridge Enters Full Service
*
Both Tracks Are Now in Operation, Retiring the 116-Year-Old Swing Bridge and Delivering a Modern Crossing for the Nation's Busiest Rail Corridor
KEARNY, NJ -- New Jersey Governor Mikie Sherrill joined NJ TRANSIT and Amtrak officials in Kearny to celebrate the historic milestone of the completion of the Portal North Bridge. Both tracks on the new bridge are now in full service following a successful five-week ... Show Full Article WASHINGTON, Nov. 16 -- Amtrak (National Railroad Passenger Corp.) issued the following news: * * * NJ TRANSIT and Amtrak Mark Historic Milestone as Portal North Bridge Enters Full Service * Both Tracks Are Now in Operation, Retiring the 116-Year-Old Swing Bridge and Delivering a Modern Crossing for the Nation's Busiest Rail Corridor KEARNY, NJ -- New Jersey Governor Mikie Sherrill joined NJ TRANSIT and Amtrak officials in Kearny to celebrate the historic milestone of the completion of the Portal North Bridge. Both tracks on the new bridge are now in full service following a successful five-weekcutover process. This achievement officially retires the 116-year-old swing bridge over the Hackensack River and marks a transformational upgrade to the nation's busiest rail corridor. NJ TRANSIT and Amtrak customers now benefit from a modern, more reliable infrastructure, ushering in a new era of dependable service for generations to come. The new Portal North Bridge is a fixed span bridge that does not have to open for marine traffic to pass under.
"The cutover is complete, and Portal North Bridge is ready to deliver," said Amtrak Interim President Byl Herrmann. "Thanks to the hard work of our crews, and our strong partnership with NJ TRANSIT, both of our customers can now experience the full benefits of the bridge with more reliable, faster service."
"New Jersey commuters deserve to get to work on time and get home to their families without a century-old bridge holding up the entire Northeast Corridor," said Governor Mikie Sherrill. "With both tracks of the Portal North Bridge now in service, we are eliminating a major source of delays and delivering the reliable transportation our residents and economy depend on. I thank the workers who built this bridge and our customers for their patience during construction. This is a major step forward for Gateway, and proof of what we can accomplish when we stay focused on getting things built."
"For too long, New Jersey commuters faced frustrating delays because of the aging Portal Bridge, which served the region from 1910 through this October. That's why I fought for more than a decade to secure federal funding for its replacement, including helping pass the 2021 Bipartisan Infrastructure Law and 2021 American Rescue Plan," said Senator Cory Booker. "I'm proud to have helped secure the critical federal investments to make this project and today's ribbon-cutting a reality. The completion of the Portal North Bridge project -- the first of the Gateway Program's 11 projects completed -- means fewer delays, more reliable service, and a better commute for the thousands of New Jerseyans who depend on our trains every day."
"With all work officially complete, commuters across North Jersey can now expect easier travels without the delays and cancellations caused by crumbling and outdated infrastructure," said Senator Andy Kim. "I look forward to seeing the positive impact the Portal North Bridge will have for New Jersey families and will continue tracking progress to ensure Gateway construction continues on schedule."
"For decades, New Jersey commuters have been at the mercy of a 116-year-old bridge that was never built to handle the demands of the busiest rail corridor in America. Those days are finally over. The completion of the Portal North Bridge is a major victory for commuters who have spent too many hours stuck on trains and waiting on platforms. I fought for the federal investments that made this project possible because our state deserves a transportation system that works as hard as the people who depend on it. Today we are delivering on that promise," said Congressman Frank Pallone (NJ-06).
"I proudly helped write, negotiate, and pass the Bipartisan Infrastructure Bill, which funds this critical project," said Congressman Josh Gottheimer (NJ-5). "The Gateway Train Tunnel Project is a massive jobs and economic engine. It will create more than 95,000 good-paying labor jobs, fuels 20 percent of our nation's GDP, and help 200,000 commuters every day."
"Completing the new Portal North Bridge is a major victory for New Jersey commuters and a critical step toward the reliable transit system they deserve," said Congressman Rob Menendez (NJ-08). "I look forward to continuing our work with New Jersey's congressional delegation, our state and local partners, and organized labor to build on this progress and keep New Jersey at the forefront of America's transit revival."
"Completing the Portal North Bridge is not only a major achievement, but a testament to when state, federal, and regional partners come together for our communities," said Congresswoman Nellie Pou (NJ-09). "Rail passengers have waited a long time and suffered through countless delays due to the old bridge and this construction project. As one of the most-used rail lines in the nation, this direct investment will provide a more reliable service for residents and commuters, allowing them to spend more time with their families and less time traveling. I am excited to witness this project come to life and look forward to the benefits that it will provide to our North Jersey communities."
"Good transit connects people to good opportunities and creates good outcomes for all our communities--that's why my colleagues and I have fought so hard for this project," said Congresswoman LaMonica McIver (NJ-10). "The Portal North Bridge will make life easier and smoother for so many residents of our districts who rely on train travel every day and will bolster our families and economies. Thank you to the engineering teams and train crews who pour their time and energy into this work, I am so excited to keep breaking ground and cutting ribbons for transportation all around NJ."
"The completion of the Portal North Bridge is a major milestone for New Jersey commuters and an important investment in the future of our region's transportation infrastructure," said Congressman Herb Conaway Jr., MD (NJ-03). "For far too long, the aging Portal Bridge has been a source of delays and frustration for the hundreds of thousands of people who rely on the Northeast Corridor. This new bridge will improve reliability, strengthen our rail infrastructure, and help keep New Jersey moving. I'm proud to see this project reach the finish line and grateful to everyone at the federal, state, and local levels who helped make it possible."
"For too long, New Jersey commuters have lost precious time with their families, missed work, and faced unnecessary stress because of disruptions in our rail service," said Congresswoman Analilia Mejia (NJ-11). "The opening of the Portal North Bridge not only modernizes our infrastructure but also gives our communities their time back. I'm grateful to Amtrak, NJ TRANSIT, Governor Sherrill and our state and federal partners for making this possible. This is an important step toward the reliable transportation our communities deserve, and I'll keep fighting for the investments needed to get New Jerseyans where they need to go, safely and on time."
"I have long supported replacing Portal Bridge because reliable transportation and good-paying union jobs are essential to New Jersey's future," said New Jersey Assembly Speaker Craig Coughlin. "Today's completion shows what sustained public investment and a skilled union workforce can deliver. The Assembly will continue working with our state and federal partners to advance the broader Gateway Program, including the Hudson Tunnel Project, and see these essential improvements through to completion."
"The completion of the Portal North Bridge marks a monumental victory for New Jersey commuters and the entire Northeast Corridor," said Senator Patrick J. Diegnan Jr. "For generations, the antiquated 116-year-old swing bridge was an unavoidable bottleneck that caused endless frustration and costly delays for our residents. By replacing it with a modern, high-level, fixed-span bridge, we are finally turning the page on chronic delays, boosting service reliability, and laying a strong foundation for future economic and transit growth. This milestone proves what we can achieve through steadfast federal, state, and regional partnership."
"The partnership between NJ TRANSIT, Amtrak, and the Trump Administration to deliver this brand-new bridge is historic. The Trump Administration's massive $771 million investment will pay dividends when riders get to their destination safer, faster, and more affordably than before. This is all part of the Administration's vision for the Golden Age of Rail in America." said FRA Administrator David Fink.
"The Federal Transit Administration has been proud to support NJ TRANSIT and Amtrak with the construction of Portal North Bridge through its investment of $926 million," said FTA Region 2 Administrator Michael Culotta. "The new fixed bridge is a game changer for workers and residents in New Jersey, and it means less delays during our commutes, more family time, and better access to education, health care, and job opportunities in our region."
"The completion of the new Portal North Bridge is a historic achievement made possible by the strong partnership and collaboration among NJ TRANSIT, Amtrak, and our federal, state, and regional partners," said NJ DOT Commissioner and NJ TRANSIT Board Chair Priya Jain. "This investment will benefit generations of customers and demonstrates what is possible when agencies work together with a shared commitment to progress."
"Today, our customers begin benefiting from a generational investment that will make their trips more reliable for decades to come," said NJ TRANSIT President & CEO Kris Kolluri. "The new Portal North Bridge permanently removes a chronic source of delays, allowing marine traffic to pass beneath the bridge without interrupting the trains carrying our customers to work, home and everywhere in between. We know both cutover projects asked a great deal of our customers, and I thank them for their patience throughout this historic transition."
"The completion of the new Portal North Bridge is a milestone for the history books," said Gateway Development Commission CEO Tom Prendergast. "Today's achievement sends a clear message: the fast, reliable commute that hundreds of thousands of daily riders have long awaited is on the horizon. Together with the Hudson Tunnel Project, we are making meaningful progress towards a stronger transportation network and proving that we can deliver on the promise of a new day for American infrastructure. The Gateway Development Commission congratulates its partners at NJ TRANSIT and Amtrak on this momentous occasion."
"This is a great day for organized labor and hard-working men and women in our union trades to be proud," said Hudson County Building & Construction Trades Council President Patrick Kelleher. "This remarkable achievement in construction and engineering is further proof that our members are building the infrastructure that America will rely on for the next 100 years. We stand ready, willing and able to continue modernizing transportation in the region."
The transfer of rail service from the 116-year-old Portal Bridge to the first track of the new Portal North Bridge began on February 13 and finished on March 15, bringing the new span's initial track into service while the old swing bridge remained operational. Work on the second and final track began on October 9 and concluded on November 16, completing the full transition to the modern bridge.
Regular NJ TRANSIT weekend service resumed on Sunday, November 15 with regular weekday service resuming today, Monday, November 16. Weekday diversions of Midtown Direct service to Hoboken and cross honoring options have ended with full service resuming between Newark and Secaucus. Customers are encouraged to consult the timetables for the latest schedules HERE.
Portal North Bridge - Project Background
The Portal North Bridge is a new modern two-track, high-level, fixed-span bridge that will improve service and capacity along this section of the Northeast Corridor. The new Portal North Bridge rises 50 feet over the Hackensack River, doubling the height clearance and allows marine traffic to pass underneath without interrupting rail traffic.
The project eliminates the 116-year-old swing bridge, which has been the enduring source of major service disruptions for NJ TRANSIT and Amtrak customers traveling on the Northeast Corridor. The new bridge provides:
* Improved reliability and fewer bridge-related delays
* Increased operational resilience along the Northeast Corridor
* A modern structure designed to support future capacity growth
The project was funded by the U.S. Department of Transportation, New Jersey, New York, and Amtrak. In January 2021, former Governor Phil Murphy announced the signing of a Full Funding Grant Agreement which secured $766.5 million in Federal Transit Administration funding to support the project's construction.
In October 2021, former Governor Murphy and NJ TRANSIT announced the approval of a $1,559,993,000 construction contract awarded to Skanska/Traylor Bros PNB Joint Venture (STJV) for the construction of the new Portal North Bridge. The contract represents the single largest construction award in NJ TRANSIT's history.
The Portal North Bridge project spans 2.44 miles of the Northeast Corridor line and includes construction of retaining walls, deep foundations, concrete piers, structural steel bridge spans, rail systems, demolition of the existing bridge, and related incidental works. The project is a critical component of the larger Gateway Program, which will eventually double rail capacity between Newark and New York.
Estimated Materials Quantities:
* 45M LB (23K Tons) of Steel
* 219K CY of Concrete
* 185K LF (35+ Miles) of Pipe Piles
* 20K LF (3+ Miles) of Drilled Shafts
* 4,850 LF of Retaining Walls
* 3,289 LF of Construction Access Platforms
The current Portal Bridge is scheduled to be dismantled in 2027.
***
Original text here: https://media.amtrak.com/2026/11/nj-transit-and-amtrak-mark-historic-milestone-as-portal-north-bridge-enters-full-service/
* * *
NJ TRANSIT and Amtrak Mark Historic Milestone as Portal North Bridge Enters Full Service
*
Both Tracks Are Now in Operation, Retiring the 116-Year-Old Swing Bridge and Delivering a Modern Crossing for the Nation's Busiest Rail Corridor
KEARNY, NJ -- New Jersey Governor Mikie Sherrill joined NJ TRANSIT and Amtrak officials in Kearny to celebrate the historic milestone of the completion of the Portal North Bridge. Both tracks on the new bridge are now in full service following a successful five-week ... Show Full Article WASHINGTON, Nov. 16 -- Amtrak (National Railroad Passenger Corp.) issued the following news: * * * NJ TRANSIT and Amtrak Mark Historic Milestone as Portal North Bridge Enters Full Service * Both Tracks Are Now in Operation, Retiring the 116-Year-Old Swing Bridge and Delivering a Modern Crossing for the Nation's Busiest Rail Corridor KEARNY, NJ -- New Jersey Governor Mikie Sherrill joined NJ TRANSIT and Amtrak officials in Kearny to celebrate the historic milestone of the completion of the Portal North Bridge. Both tracks on the new bridge are now in full service following a successful five-weekcutover process. This achievement officially retires the 116-year-old swing bridge over the Hackensack River and marks a transformational upgrade to the nation's busiest rail corridor. NJ TRANSIT and Amtrak customers now benefit from a modern, more reliable infrastructure, ushering in a new era of dependable service for generations to come. The new Portal North Bridge is a fixed span bridge that does not have to open for marine traffic to pass under.
"The cutover is complete, and Portal North Bridge is ready to deliver," said Amtrak Interim President Byl Herrmann. "Thanks to the hard work of our crews, and our strong partnership with NJ TRANSIT, both of our customers can now experience the full benefits of the bridge with more reliable, faster service."
"New Jersey commuters deserve to get to work on time and get home to their families without a century-old bridge holding up the entire Northeast Corridor," said Governor Mikie Sherrill. "With both tracks of the Portal North Bridge now in service, we are eliminating a major source of delays and delivering the reliable transportation our residents and economy depend on. I thank the workers who built this bridge and our customers for their patience during construction. This is a major step forward for Gateway, and proof of what we can accomplish when we stay focused on getting things built."
"For too long, New Jersey commuters faced frustrating delays because of the aging Portal Bridge, which served the region from 1910 through this October. That's why I fought for more than a decade to secure federal funding for its replacement, including helping pass the 2021 Bipartisan Infrastructure Law and 2021 American Rescue Plan," said Senator Cory Booker. "I'm proud to have helped secure the critical federal investments to make this project and today's ribbon-cutting a reality. The completion of the Portal North Bridge project -- the first of the Gateway Program's 11 projects completed -- means fewer delays, more reliable service, and a better commute for the thousands of New Jerseyans who depend on our trains every day."
"With all work officially complete, commuters across North Jersey can now expect easier travels without the delays and cancellations caused by crumbling and outdated infrastructure," said Senator Andy Kim. "I look forward to seeing the positive impact the Portal North Bridge will have for New Jersey families and will continue tracking progress to ensure Gateway construction continues on schedule."
"For decades, New Jersey commuters have been at the mercy of a 116-year-old bridge that was never built to handle the demands of the busiest rail corridor in America. Those days are finally over. The completion of the Portal North Bridge is a major victory for commuters who have spent too many hours stuck on trains and waiting on platforms. I fought for the federal investments that made this project possible because our state deserves a transportation system that works as hard as the people who depend on it. Today we are delivering on that promise," said Congressman Frank Pallone (NJ-06).
"I proudly helped write, negotiate, and pass the Bipartisan Infrastructure Bill, which funds this critical project," said Congressman Josh Gottheimer (NJ-5). "The Gateway Train Tunnel Project is a massive jobs and economic engine. It will create more than 95,000 good-paying labor jobs, fuels 20 percent of our nation's GDP, and help 200,000 commuters every day."
"Completing the new Portal North Bridge is a major victory for New Jersey commuters and a critical step toward the reliable transit system they deserve," said Congressman Rob Menendez (NJ-08). "I look forward to continuing our work with New Jersey's congressional delegation, our state and local partners, and organized labor to build on this progress and keep New Jersey at the forefront of America's transit revival."
"Completing the Portal North Bridge is not only a major achievement, but a testament to when state, federal, and regional partners come together for our communities," said Congresswoman Nellie Pou (NJ-09). "Rail passengers have waited a long time and suffered through countless delays due to the old bridge and this construction project. As one of the most-used rail lines in the nation, this direct investment will provide a more reliable service for residents and commuters, allowing them to spend more time with their families and less time traveling. I am excited to witness this project come to life and look forward to the benefits that it will provide to our North Jersey communities."
"Good transit connects people to good opportunities and creates good outcomes for all our communities--that's why my colleagues and I have fought so hard for this project," said Congresswoman LaMonica McIver (NJ-10). "The Portal North Bridge will make life easier and smoother for so many residents of our districts who rely on train travel every day and will bolster our families and economies. Thank you to the engineering teams and train crews who pour their time and energy into this work, I am so excited to keep breaking ground and cutting ribbons for transportation all around NJ."
"The completion of the Portal North Bridge is a major milestone for New Jersey commuters and an important investment in the future of our region's transportation infrastructure," said Congressman Herb Conaway Jr., MD (NJ-03). "For far too long, the aging Portal Bridge has been a source of delays and frustration for the hundreds of thousands of people who rely on the Northeast Corridor. This new bridge will improve reliability, strengthen our rail infrastructure, and help keep New Jersey moving. I'm proud to see this project reach the finish line and grateful to everyone at the federal, state, and local levels who helped make it possible."
"For too long, New Jersey commuters have lost precious time with their families, missed work, and faced unnecessary stress because of disruptions in our rail service," said Congresswoman Analilia Mejia (NJ-11). "The opening of the Portal North Bridge not only modernizes our infrastructure but also gives our communities their time back. I'm grateful to Amtrak, NJ TRANSIT, Governor Sherrill and our state and federal partners for making this possible. This is an important step toward the reliable transportation our communities deserve, and I'll keep fighting for the investments needed to get New Jerseyans where they need to go, safely and on time."
"I have long supported replacing Portal Bridge because reliable transportation and good-paying union jobs are essential to New Jersey's future," said New Jersey Assembly Speaker Craig Coughlin. "Today's completion shows what sustained public investment and a skilled union workforce can deliver. The Assembly will continue working with our state and federal partners to advance the broader Gateway Program, including the Hudson Tunnel Project, and see these essential improvements through to completion."
"The completion of the Portal North Bridge marks a monumental victory for New Jersey commuters and the entire Northeast Corridor," said Senator Patrick J. Diegnan Jr. "For generations, the antiquated 116-year-old swing bridge was an unavoidable bottleneck that caused endless frustration and costly delays for our residents. By replacing it with a modern, high-level, fixed-span bridge, we are finally turning the page on chronic delays, boosting service reliability, and laying a strong foundation for future economic and transit growth. This milestone proves what we can achieve through steadfast federal, state, and regional partnership."
"The partnership between NJ TRANSIT, Amtrak, and the Trump Administration to deliver this brand-new bridge is historic. The Trump Administration's massive $771 million investment will pay dividends when riders get to their destination safer, faster, and more affordably than before. This is all part of the Administration's vision for the Golden Age of Rail in America." said FRA Administrator David Fink.
"The Federal Transit Administration has been proud to support NJ TRANSIT and Amtrak with the construction of Portal North Bridge through its investment of $926 million," said FTA Region 2 Administrator Michael Culotta. "The new fixed bridge is a game changer for workers and residents in New Jersey, and it means less delays during our commutes, more family time, and better access to education, health care, and job opportunities in our region."
"The completion of the new Portal North Bridge is a historic achievement made possible by the strong partnership and collaboration among NJ TRANSIT, Amtrak, and our federal, state, and regional partners," said NJ DOT Commissioner and NJ TRANSIT Board Chair Priya Jain. "This investment will benefit generations of customers and demonstrates what is possible when agencies work together with a shared commitment to progress."
"Today, our customers begin benefiting from a generational investment that will make their trips more reliable for decades to come," said NJ TRANSIT President & CEO Kris Kolluri. "The new Portal North Bridge permanently removes a chronic source of delays, allowing marine traffic to pass beneath the bridge without interrupting the trains carrying our customers to work, home and everywhere in between. We know both cutover projects asked a great deal of our customers, and I thank them for their patience throughout this historic transition."
"The completion of the new Portal North Bridge is a milestone for the history books," said Gateway Development Commission CEO Tom Prendergast. "Today's achievement sends a clear message: the fast, reliable commute that hundreds of thousands of daily riders have long awaited is on the horizon. Together with the Hudson Tunnel Project, we are making meaningful progress towards a stronger transportation network and proving that we can deliver on the promise of a new day for American infrastructure. The Gateway Development Commission congratulates its partners at NJ TRANSIT and Amtrak on this momentous occasion."
"This is a great day for organized labor and hard-working men and women in our union trades to be proud," said Hudson County Building & Construction Trades Council President Patrick Kelleher. "This remarkable achievement in construction and engineering is further proof that our members are building the infrastructure that America will rely on for the next 100 years. We stand ready, willing and able to continue modernizing transportation in the region."
The transfer of rail service from the 116-year-old Portal Bridge to the first track of the new Portal North Bridge began on February 13 and finished on March 15, bringing the new span's initial track into service while the old swing bridge remained operational. Work on the second and final track began on October 9 and concluded on November 16, completing the full transition to the modern bridge.
Regular NJ TRANSIT weekend service resumed on Sunday, November 15 with regular weekday service resuming today, Monday, November 16. Weekday diversions of Midtown Direct service to Hoboken and cross honoring options have ended with full service resuming between Newark and Secaucus. Customers are encouraged to consult the timetables for the latest schedules HERE.
Portal North Bridge - Project Background
The Portal North Bridge is a new modern two-track, high-level, fixed-span bridge that will improve service and capacity along this section of the Northeast Corridor. The new Portal North Bridge rises 50 feet over the Hackensack River, doubling the height clearance and allows marine traffic to pass underneath without interrupting rail traffic.
The project eliminates the 116-year-old swing bridge, which has been the enduring source of major service disruptions for NJ TRANSIT and Amtrak customers traveling on the Northeast Corridor. The new bridge provides:
* Improved reliability and fewer bridge-related delays
* Increased operational resilience along the Northeast Corridor
* A modern structure designed to support future capacity growth
The project was funded by the U.S. Department of Transportation, New Jersey, New York, and Amtrak. In January 2021, former Governor Phil Murphy announced the signing of a Full Funding Grant Agreement which secured $766.5 million in Federal Transit Administration funding to support the project's construction.
In October 2021, former Governor Murphy and NJ TRANSIT announced the approval of a $1,559,993,000 construction contract awarded to Skanska/Traylor Bros PNB Joint Venture (STJV) for the construction of the new Portal North Bridge. The contract represents the single largest construction award in NJ TRANSIT's history.
The Portal North Bridge project spans 2.44 miles of the Northeast Corridor line and includes construction of retaining walls, deep foundations, concrete piers, structural steel bridge spans, rail systems, demolition of the existing bridge, and related incidental works. The project is a critical component of the larger Gateway Program, which will eventually double rail capacity between Newark and New York.
Estimated Materials Quantities:
* 45M LB (23K Tons) of Steel
* 219K CY of Concrete
* 185K LF (35+ Miles) of Pipe Piles
* 20K LF (3+ Miles) of Drilled Shafts
* 4,850 LF of Retaining Walls
* 3,289 LF of Construction Access Platforms
The current Portal Bridge is scheduled to be dismantled in 2027.
***
Original text here: https://media.amtrak.com/2026/11/nj-transit-and-amtrak-mark-historic-milestone-as-portal-north-bridge-enters-full-service/
Media Advisory: Holiday Offerings at the National Gallery of Art
WASHINGTON, Nov. 16 -- The National Gallery of Art posted the following news release:
* * *
Media Advisory: Holiday Offerings at the National Gallery of Art
*
The National Gallery of Art is home to holiday traditions of all kinds, for all ages. Visitors can enjoy activities with family and friends, do their holiday shopping, make art of their own, go ice skating, or wind down with art from throughout history. Admission to the museum and programs is always free.
The National Gallery will be closed on December 25 and January 1.
Recurring Activities
November 14, 2026-January 3, 2027, 10:00 ... Show Full Article WASHINGTON, Nov. 16 -- The National Gallery of Art posted the following news release: * * * Media Advisory: Holiday Offerings at the National Gallery of Art * The National Gallery of Art is home to holiday traditions of all kinds, for all ages. Visitors can enjoy activities with family and friends, do their holiday shopping, make art of their own, go ice skating, or wind down with art from throughout history. Admission to the museum and programs is always free. The National Gallery will be closed on December 25 and January 1. Recurring Activities November 14, 2026-January 3, 2027, 10:00a.m.-5:00 p.m., East Building Atrium (excluding December 18)
Artmaking stations will be available throughout the holiday season for people of all ages and abilities.
Winter Displays and Photo Opportunities
Our West Building Rotunda will be filled with evergreen trees, poinsettias, and more--the perfect background for a holiday photo with family or friends at our dedicated selfie station, open December 5 to January 3. Both the Rotunda and our East Building Atrium will also be the sites of holiday performances throughout December.
December 5, 12, 19, 26, 10:15-11:00 a.m., East Building Auditorium
Children can enjoy a series of short films from the New York International Children's Film Festival.
December 5, 12, 19, 26, 11:15 a.m.-12:30 p.m., East Building Auditorium
This series of short films from all over the world is full of questions for slightly older kids.
The seasonal favorite Sculpture Garden Ice Rink returns November 23. Skate under the stars of the National Mall seven days a week (weather permitting). Pop into the Pavilion Cafe and enjoy hot chocolate or warm cider between sessions. Lessons and group sessions are available.
Other Programs
December 5, 10:00 a.m.-3:00 p.m., East Building Atrium and Concourse
This monthly festival will be filled with holiday-themed activities for the whole family, including:
* Caroling in the West Building Rotunda, 12:00-2:00 p.m.
* Artist ornament making
* Artmaking
* Artisan trunk show with pieces by local artists available for purchase
* Family yoga
* Facepainting
Performance: "Clarinet Christmas"
December 12, 12:30-1:30 p.m., East Building Atrium
This DC holiday tradition offers a holiday concert and sing-along to the tune of 150 clarinets. Clarinetists that would like to join the ensemble can sign up here.
Film Screening: Who Killed Santa Claus (1941)
December 20, 2:00-3:45 p.m.
A small village nestled in the snowy French Alps is rocked by several unexpected twists to its traditional Christmas. This charming film by Christian-Jacque features delicately drawn characters, romance, comedy, and mysteries shown through beautiful black-and-white images. Part of From the Vaults: Recent Film Restorations, a five-part series presented between December 12 and 27.
Food, Beverage, and Retail
New seasonal items join the winter menu offerings at National Gallery Cafes. Highlights include braised short rib, an heirloom turkey bacon BLT, and seasonal eggnog. Visit our shops, filled with the latest apparel, jewelry, books, and more.
Winter Highlights from the Collection
Adam van Breen, Skating on the Frozen Amstel River, 1611 (West Building, Gallery M50)
This detailed winter scene depicts people from all walks of life ice skating on the frozen Amstel River. After exploring this image, visitors can enjoy sumptuous still life paintings and works by Johannes Vermeer nearby.
Camille Pissarro, Boulevard des Italiens, Morning, Sunlight, 1897 (West Building, Gallery M89)
Pissarro depicts a recently renewed Paris boulevard on a busy winter day, giving viewers a peek into late 19th-century Parisian life, from commuter buses and horse-drawn carriages to the fashion of the pedestrians.
Gilbert Stuart, The Skater (Portrait of William Grant), 1782 (West Building, Gallery M59)
Inspired by an impromptu skating session with his subject, this classic winter work catapulted Stuart to fame. He later painted the portrait of George Washington used on the dollar bill.
Henri Matisse, Pianist and Checker Players, 1924 (East Building, Gallery E103)
Yellow and red tones and a variety of patterns contribute to the warmth of a cozy scene that may remind viewers of their own family holiday gatherings.
INTERVIEWS
Grace Murray Stone, head of public programs, is available for interview on First Saturday and other programmatic offerings. Emme Porter, skating director, is available for interview on the Ice Rink.
ASSETS
Unless otherwise noted, images are attributable to the National Gallery of Art.
CONTACT
Chris Abanavas, c-abanavas@nga.gov, (202) 842-6358
Nyree Berry, n-berry@nga.gov, (202) 842-6589
Contact Information
You may also like
Press Release: National Gallery of Art Announces Eight New US Museums to Receive Loans of Masterworks, Fully Funded through Across the Nation Program
Launched in 2025 to commemorate America's 250th anniversary, Across the Nation has been endowed with a monumental gift of $116 million from The Mitchell P. Rales Family Foundation, allowing it to continue in perpetuity.
***
Original text here: https://www.nga.gov/press/media-advisory-holiday-offerings
* * *
Media Advisory: Holiday Offerings at the National Gallery of Art
*
The National Gallery of Art is home to holiday traditions of all kinds, for all ages. Visitors can enjoy activities with family and friends, do their holiday shopping, make art of their own, go ice skating, or wind down with art from throughout history. Admission to the museum and programs is always free.
The National Gallery will be closed on December 25 and January 1.
Recurring Activities
November 14, 2026-January 3, 2027, 10:00 ... Show Full Article WASHINGTON, Nov. 16 -- The National Gallery of Art posted the following news release: * * * Media Advisory: Holiday Offerings at the National Gallery of Art * The National Gallery of Art is home to holiday traditions of all kinds, for all ages. Visitors can enjoy activities with family and friends, do their holiday shopping, make art of their own, go ice skating, or wind down with art from throughout history. Admission to the museum and programs is always free. The National Gallery will be closed on December 25 and January 1. Recurring Activities November 14, 2026-January 3, 2027, 10:00a.m.-5:00 p.m., East Building Atrium (excluding December 18)
Artmaking stations will be available throughout the holiday season for people of all ages and abilities.
Winter Displays and Photo Opportunities
Our West Building Rotunda will be filled with evergreen trees, poinsettias, and more--the perfect background for a holiday photo with family or friends at our dedicated selfie station, open December 5 to January 3. Both the Rotunda and our East Building Atrium will also be the sites of holiday performances throughout December.
December 5, 12, 19, 26, 10:15-11:00 a.m., East Building Auditorium
Children can enjoy a series of short films from the New York International Children's Film Festival.
December 5, 12, 19, 26, 11:15 a.m.-12:30 p.m., East Building Auditorium
This series of short films from all over the world is full of questions for slightly older kids.
The seasonal favorite Sculpture Garden Ice Rink returns November 23. Skate under the stars of the National Mall seven days a week (weather permitting). Pop into the Pavilion Cafe and enjoy hot chocolate or warm cider between sessions. Lessons and group sessions are available.
Other Programs
December 5, 10:00 a.m.-3:00 p.m., East Building Atrium and Concourse
This monthly festival will be filled with holiday-themed activities for the whole family, including:
* Caroling in the West Building Rotunda, 12:00-2:00 p.m.
* Artist ornament making
* Artmaking
* Artisan trunk show with pieces by local artists available for purchase
* Family yoga
* Facepainting
Performance: "Clarinet Christmas"
December 12, 12:30-1:30 p.m., East Building Atrium
This DC holiday tradition offers a holiday concert and sing-along to the tune of 150 clarinets. Clarinetists that would like to join the ensemble can sign up here.
Film Screening: Who Killed Santa Claus (1941)
December 20, 2:00-3:45 p.m.
A small village nestled in the snowy French Alps is rocked by several unexpected twists to its traditional Christmas. This charming film by Christian-Jacque features delicately drawn characters, romance, comedy, and mysteries shown through beautiful black-and-white images. Part of From the Vaults: Recent Film Restorations, a five-part series presented between December 12 and 27.
Food, Beverage, and Retail
New seasonal items join the winter menu offerings at National Gallery Cafes. Highlights include braised short rib, an heirloom turkey bacon BLT, and seasonal eggnog. Visit our shops, filled with the latest apparel, jewelry, books, and more.
Winter Highlights from the Collection
Adam van Breen, Skating on the Frozen Amstel River, 1611 (West Building, Gallery M50)
This detailed winter scene depicts people from all walks of life ice skating on the frozen Amstel River. After exploring this image, visitors can enjoy sumptuous still life paintings and works by Johannes Vermeer nearby.
Camille Pissarro, Boulevard des Italiens, Morning, Sunlight, 1897 (West Building, Gallery M89)
Pissarro depicts a recently renewed Paris boulevard on a busy winter day, giving viewers a peek into late 19th-century Parisian life, from commuter buses and horse-drawn carriages to the fashion of the pedestrians.
Gilbert Stuart, The Skater (Portrait of William Grant), 1782 (West Building, Gallery M59)
Inspired by an impromptu skating session with his subject, this classic winter work catapulted Stuart to fame. He later painted the portrait of George Washington used on the dollar bill.
Henri Matisse, Pianist and Checker Players, 1924 (East Building, Gallery E103)
Yellow and red tones and a variety of patterns contribute to the warmth of a cozy scene that may remind viewers of their own family holiday gatherings.
INTERVIEWS
Grace Murray Stone, head of public programs, is available for interview on First Saturday and other programmatic offerings. Emme Porter, skating director, is available for interview on the Ice Rink.
ASSETS
Unless otherwise noted, images are attributable to the National Gallery of Art.
CONTACT
Chris Abanavas, c-abanavas@nga.gov, (202) 842-6358
Nyree Berry, n-berry@nga.gov, (202) 842-6589
Contact Information
You may also like
Press Release: National Gallery of Art Announces Eight New US Museums to Receive Loans of Masterworks, Fully Funded through Across the Nation Program
Launched in 2025 to commemorate America's 250th anniversary, Across the Nation has been endowed with a monumental gift of $116 million from The Mitchell P. Rales Family Foundation, allowing it to continue in perpetuity.
***
Original text here: https://www.nga.gov/press/media-advisory-holiday-offerings
EPA's Feed it Onward Program Partners with Chicago Food Rescue to Prevent Food Waste
WASHINGTON, Nov. 16 -- The Environmental Protection Agency issued the following news release:
* * *
EPA's Feed it Onward Program Partners with Chicago Food Rescue to Prevent Food Waste
*
CHICAGO (November 16, 2026) - Today, U.S. Environmental Protection Agency (EPA) announced a partnership with Chicago Food Rescue through Feed It Onward, EPA's growing network of businesses, farmers, nonprofits, and communities working to keep good food from going to waste. Chicago Food Rescue works with food donors and a network of volunteers to rescue food and deliver it to nonprofit and community partners.
"Feed ... Show Full Article WASHINGTON, Nov. 16 -- The Environmental Protection Agency issued the following news release: * * * EPA's Feed it Onward Program Partners with Chicago Food Rescue to Prevent Food Waste * CHICAGO (November 16, 2026) - Today, U.S. Environmental Protection Agency (EPA) announced a partnership with Chicago Food Rescue through Feed It Onward, EPA's growing network of businesses, farmers, nonprofits, and communities working to keep good food from going to waste. Chicago Food Rescue works with food donors and a network of volunteers to rescue food and deliver it to nonprofit and community partners. "FeedIt Onward is about elevating practical, community-based solutions that make the best use of good food," said EPA Region 5 Administrator Anne Vogel. "By shining a spotlight on efforts like Chicago Food Rescue, EPA is helping successful models grow, connect with new partners, and reach more communities that share the goal of eliminating food waste."
Under Administrator Lee Zeldin's leadership, EPA launched Feed It Onward to highlight practical solutions already working across America and help those ideas go further. Feed It Onward shares what is working and gives successful efforts a national platform so that organizations doing this work can come together.
Chicago Food Rescue works with restaurants, banquet halls and grocery stores to collect extra food before it is thrown away. Volunteers pick up the food to deliver to food banks, churches and other community groups that help feed people. By joining Feed It Onward, Chicago Food Rescue will share lessons learned and connect with other groups working to make better use of food in their communities.
"At Chicago Food Rescue, we believe good food should feed people, not landfills," said Jake Tepperman, founder and executive director of Chicago Food Rescue. "Every day, our volunteers pick up surplus food from local food businesses and deliver it directly to community organizations feeding our neighbors. So far this year, we've rescued more than 440,000 pounds of food, the equivalent of over 360,000 meals. Partnerships like this one help us reach more food donors and keep even more good food in our community."
More information about Feed It Onward.
More information about Chicago Food Rescue.
***
Original text here: https://www.epa.gov/newsreleases/epas-feed-it-onward-program-partners-chicago-food-rescue-prevent-food-waste
* * *
EPA's Feed it Onward Program Partners with Chicago Food Rescue to Prevent Food Waste
*
CHICAGO (November 16, 2026) - Today, U.S. Environmental Protection Agency (EPA) announced a partnership with Chicago Food Rescue through Feed It Onward, EPA's growing network of businesses, farmers, nonprofits, and communities working to keep good food from going to waste. Chicago Food Rescue works with food donors and a network of volunteers to rescue food and deliver it to nonprofit and community partners.
"Feed ... Show Full Article WASHINGTON, Nov. 16 -- The Environmental Protection Agency issued the following news release: * * * EPA's Feed it Onward Program Partners with Chicago Food Rescue to Prevent Food Waste * CHICAGO (November 16, 2026) - Today, U.S. Environmental Protection Agency (EPA) announced a partnership with Chicago Food Rescue through Feed It Onward, EPA's growing network of businesses, farmers, nonprofits, and communities working to keep good food from going to waste. Chicago Food Rescue works with food donors and a network of volunteers to rescue food and deliver it to nonprofit and community partners. "FeedIt Onward is about elevating practical, community-based solutions that make the best use of good food," said EPA Region 5 Administrator Anne Vogel. "By shining a spotlight on efforts like Chicago Food Rescue, EPA is helping successful models grow, connect with new partners, and reach more communities that share the goal of eliminating food waste."
Under Administrator Lee Zeldin's leadership, EPA launched Feed It Onward to highlight practical solutions already working across America and help those ideas go further. Feed It Onward shares what is working and gives successful efforts a national platform so that organizations doing this work can come together.
Chicago Food Rescue works with restaurants, banquet halls and grocery stores to collect extra food before it is thrown away. Volunteers pick up the food to deliver to food banks, churches and other community groups that help feed people. By joining Feed It Onward, Chicago Food Rescue will share lessons learned and connect with other groups working to make better use of food in their communities.
"At Chicago Food Rescue, we believe good food should feed people, not landfills," said Jake Tepperman, founder and executive director of Chicago Food Rescue. "Every day, our volunteers pick up surplus food from local food businesses and deliver it directly to community organizations feeding our neighbors. So far this year, we've rescued more than 440,000 pounds of food, the equivalent of over 360,000 meals. Partnerships like this one help us reach more food donors and keep even more good food in our community."
More information about Feed It Onward.
More information about Chicago Food Rescue.
***
Original text here: https://www.epa.gov/newsreleases/epas-feed-it-onward-program-partners-chicago-food-rescue-prevent-food-waste
EPA Approves Louisiana's Coal Combustion Residuals Permit Program
WASHINGTON, Nov. 16 -- The Environmental Protection Agency issued the following news release:
* * *
EPA Approves Louisiana's Coal Combustion Residuals Permit Program
*
WASHINGTON -- Today, U.S. Environmental Protection Agency (EPA) announced the final approval of the state of Louisiana's coal combustion residuals (CCR) permit program. This action will allow the state, rather than the federal government, to permit CCR disposal in surface impoundments and landfills. This approval advances EPA's goal of restoring American energy dominance and strengthening cooperative federalism while protecting ... Show Full Article WASHINGTON, Nov. 16 -- The Environmental Protection Agency issued the following news release: * * * EPA Approves Louisiana's Coal Combustion Residuals Permit Program * WASHINGTON -- Today, U.S. Environmental Protection Agency (EPA) announced the final approval of the state of Louisiana's coal combustion residuals (CCR) permit program. This action will allow the state, rather than the federal government, to permit CCR disposal in surface impoundments and landfills. This approval advances EPA's goal of restoring American energy dominance and strengthening cooperative federalism while protectinghuman health and the environment.
"Today's approval is a win for cooperative federalism and for Louisiana," said EPA Administrator Lee Zeldin. "By empowering the state's experts who understand their communities and their energy industry best, we're protecting human health, delivering the regulatory certainty industry needs, and helping power the Great American Comeback."
"This approval delivers on EPA's message that states know how best to maintain their economies and public health without overlapping federal oversight," said Region 6 Administrator Scott Mason. "By working with LDEQ, we are able to deliver a single set of regulations that empowers Louisiana's energy sector while still protecting human health and the environment. EPA will continue to engage our state partners to ensure businesses have a clear understanding of the law to power their economies."
After reviewing the application from the Louisiana Department of Environmental Quality, EPA determined that the program met all the standards for approval.
Under the Trump administration, EPA has made significant progress working with states as they seek to manage their own CCR programs. Throughout President Trump's two terms in office, EPA has set the stage for 10 states to receive CCR program approval. Louisiana is the seventh state to have its CCR permit program approved by EPA.
EPA will continue working with state partners to prioritize timely action and empower those with local expertise to oversee more effective CCR disposal operations. The agency anticipates finalizing other CCR permit program decisions in the near future.
***
Original text here: https://www.epa.gov/newsreleases/epa-approves-louisianas-coal-combustion-residuals-permit-program
* * *
EPA Approves Louisiana's Coal Combustion Residuals Permit Program
*
WASHINGTON -- Today, U.S. Environmental Protection Agency (EPA) announced the final approval of the state of Louisiana's coal combustion residuals (CCR) permit program. This action will allow the state, rather than the federal government, to permit CCR disposal in surface impoundments and landfills. This approval advances EPA's goal of restoring American energy dominance and strengthening cooperative federalism while protecting ... Show Full Article WASHINGTON, Nov. 16 -- The Environmental Protection Agency issued the following news release: * * * EPA Approves Louisiana's Coal Combustion Residuals Permit Program * WASHINGTON -- Today, U.S. Environmental Protection Agency (EPA) announced the final approval of the state of Louisiana's coal combustion residuals (CCR) permit program. This action will allow the state, rather than the federal government, to permit CCR disposal in surface impoundments and landfills. This approval advances EPA's goal of restoring American energy dominance and strengthening cooperative federalism while protectinghuman health and the environment.
"Today's approval is a win for cooperative federalism and for Louisiana," said EPA Administrator Lee Zeldin. "By empowering the state's experts who understand their communities and their energy industry best, we're protecting human health, delivering the regulatory certainty industry needs, and helping power the Great American Comeback."
"This approval delivers on EPA's message that states know how best to maintain their economies and public health without overlapping federal oversight," said Region 6 Administrator Scott Mason. "By working with LDEQ, we are able to deliver a single set of regulations that empowers Louisiana's energy sector while still protecting human health and the environment. EPA will continue to engage our state partners to ensure businesses have a clear understanding of the law to power their economies."
After reviewing the application from the Louisiana Department of Environmental Quality, EPA determined that the program met all the standards for approval.
Under the Trump administration, EPA has made significant progress working with states as they seek to manage their own CCR programs. Throughout President Trump's two terms in office, EPA has set the stage for 10 states to receive CCR program approval. Louisiana is the seventh state to have its CCR permit program approved by EPA.
EPA will continue working with state partners to prioritize timely action and empower those with local expertise to oversee more effective CCR disposal operations. The agency anticipates finalizing other CCR permit program decisions in the near future.
***
Original text here: https://www.epa.gov/newsreleases/epa-approves-louisianas-coal-combustion-residuals-permit-program
